Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Clinical Breast Cancer|November 30, 2017
The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on SurvivalYusuf Karakas, Omer Dizdar, Sercan Aksoy, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanesNadire Kucukoztas, Arzu Oguz, Samed Rahatli, et al.
The Tohoku Journal of Experimental Medicine|July 9, 2004
Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patientsEsmen Baltali, Kadri Altundag, Yavuz Ozisik, et al.
Current Medical Research and Opinion|September 21, 2013
Everolimus: a new hope for patients with breast cancerMehmet A N Sendur, Nurullah Zengin, Sercan Aksoy, et al.
Cancer|May 16, 2007
Manipulating the chemokine-chemokine receptor network to treat cancerPier A Ruffini, Paolo Morandi, Neslihan Cabioglu, et al.
The Breast Journal|May 25, 2013
Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer PatientsSoley Bayraktar, Tiffany Avery, Kadri Altundag, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 3, 2017
Clinicopathological features of patients with breast cancer aged 70 years or overAydin Aytekin, Fatih Karatas, Suleyman Sahin, et al.
Medical Hypotheses|June 15, 2004
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cellsKadri Altundag, Ozden Altundag, Emin Tamer Elkiran, et al.
The American Surgeon|April 21, 2017
Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast CancerSuleyman Sahin, Fatih Karatas, Gokmen U Erdem, et al.
Cancer Investigation|July 31, 2007
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapySelahattin Turen, Enis Ozyar, Kadri Altundag, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Clinical Breast Cancer|November 30, 2017
The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on SurvivalYusuf Karakas, Omer Dizdar, Sercan Aksoy, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanesNadire Kucukoztas, Arzu Oguz, Samed Rahatli, et al.
The Tohoku Journal of Experimental Medicine|July 9, 2004
Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patientsEsmen Baltali, Kadri Altundag, Yavuz Ozisik, et al.
Current Medical Research and Opinion|September 21, 2013
Everolimus: a new hope for patients with breast cancerMehmet A N Sendur, Nurullah Zengin, Sercan Aksoy, et al.
Cancer|May 16, 2007
Manipulating the chemokine-chemokine receptor network to treat cancerPier A Ruffini, Paolo Morandi, Neslihan Cabioglu, et al.
The Breast Journal|May 25, 2013
Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer PatientsSoley Bayraktar, Tiffany Avery, Kadri Altundag, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 3, 2017
Clinicopathological features of patients with breast cancer aged 70 years or overAydin Aytekin, Fatih Karatas, Suleyman Sahin, et al.
Medical Hypotheses|June 15, 2004
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cellsKadri Altundag, Ozden Altundag, Emin Tamer Elkiran, et al.
The American Surgeon|April 21, 2017
Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast CancerSuleyman Sahin, Fatih Karatas, Gokmen U Erdem, et al.
Cancer Investigation|July 31, 2007
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapySelahattin Turen, Enis Ozyar, Kadri Altundag, et al.
Pageof 16